Health-related quality of life for margetuximab plus chemotherapy vs. trastuzumab plus chemotherapy in the phase 3 SOPHIA trial of patients with pretreated HER2+metastatic breast cancer Cardoso, F., Cortes, J., Gradishar, W., Im, S., Pegram, M. D., Rugo, H. S., Wright, G. S., De laurentiis, M., Levy, C., Ferrero, J., Mansi, J., Oyola, R., Ricci, F., Jakobsen, E. H., Uziely, B., Egle, D., Giagounidis, A., Williams, K., Hong, S., Rock, E., Curigliano, G. AMER ASSOC CANCER RESEARCH. 2021

View details for Web of Science ID 000618737701228